Добірка наукової літератури з теми "Leishmaniasis-Disease"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Leishmaniasis-Disease".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Leishmaniasis-Disease"
Russo, Antonio, GiovannaRusso Mancuso, ChiaraMaria Battaglini, and Gino Schilirò. "LEISHMANIASIS, A WORLDWIDE DISEASE." Lancet 327, no. 8478 (February 1986): 451–52. http://dx.doi.org/10.1016/s0140-6736(86)92413-x.
Повний текст джерелаGalanakis, E., A. Siamopoulou, and PD Lapatsanis. "Leishmaniasis mimicking collagen disease." Lancet 350, no. 9074 (August 1997): 368–69. http://dx.doi.org/10.1016/s0140-6736(05)63428-9.
Повний текст джерелаCarranza, Arturo, and Maria Polanco Garcia. "Leishmaniasis: An Unforgettable Disease." American Journal of Medicine 133, no. 11 (November 2020): e678. http://dx.doi.org/10.1016/j.amjmed.2020.04.043.
Повний текст джерелаFeiz Haddad, Mohammad Hossien, Abdolaziz Gharaei, Abdolaziz Gharaei, and Mehry Sharify Nia. "Epidemiological Study of leishmaniasis in Iran and the Middle East in the Last Two Decades." Jundishapur Journal of Medical Sciences 20, no. 2 (June 1, 2021): 86–100. http://dx.doi.org/10.32598/jsmj.20.2.6.
Повний текст джерелаAhuja, Arvind. "Duodenal Leishmaniasis Mimicking Celiac Disease." Tropical Gastroenterology 36, no. 2 (June 1, 2015): 121–23. http://dx.doi.org/10.7869/tg.266.
Повний текст джерелаShehnaz, Gul, Mahnoor Zahra, Doua Ilyas, and Aneeqa Hamida. "Leishmaniasis: A Neglected Tropical Disease." Global Immunological & Infectious Diseases Review IV, no. I (December 30, 2019): 17–23. http://dx.doi.org/10.31703/giidr.2019(iv-i).03.
Повний текст джерелаHamida, Aneeqa, Doua Ilyas, Mahnoor Zahra, and Gul Shehnaz. "Leishmaniasis: A Neglected Tropical Disease." Global Immunological & Infectious Diseases Review IV, no. I (December 30, 2019): 10–16. http://dx.doi.org/10.31703/giidr.2019(iv-i).02.
Повний текст джерелаKaziani, Katerina, Chariclea Vadala, Panagiota Stasinopoulou, Dionysios Loverdos, Michael Samarkos, and Athanasios Skoutelis. "Visceral Leishmaniasis Mimicking Lymphoproliferative Disease." Southern Medical Journal 103, no. 12 (December 2010): 1276–77. http://dx.doi.org/10.1097/smj.0b013e3181faefbd.
Повний текст джерелаMauhoub, Mansoor El, V. P. Aggarwal, M. I. Mehabreash, and F. K. Dar. "Visceral leishmaniasis: A worldwide disease." Indian Journal of Pediatrics 54, no. 1 (January 1987): 97–101. http://dx.doi.org/10.1007/bf02751247.
Повний текст джерелаMazumder, Shirin A., Soumya Pandey, Susan C. Brewer, Vickie S. Baselski, Peter J. Weina, Mack A. Land, and James M. Fleckenstein. "Lingual Leishmaniasis Complicating Visceral Disease." Journal of Travel Medicine 17, no. 3 (May 1, 2010): 212–14. http://dx.doi.org/10.1111/j.1708-8305.2010.00403.x.
Повний текст джерелаДисертації з теми "Leishmaniasis-Disease"
Yakovich, Adam J. "Old targets and new beginnings a multifaceted approach to combating Leishmaniasis, a neglected tropical disease /." Columbus, Ohio : Ohio State University, 2007. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1193247442.
Повний текст джерелаMARITATI, MARTINA. "LEISHMANIASIS: A RE-EMERGING NEGLECTED DISEASE. BIOMOLECULAR AND METABOLOMIC STUDIES AIMED AT IMPLANTING ITS CONTROL IN EMILIA-ROMAGNA." Doctoral thesis, Università degli studi di Ferrara, 2021. http://hdl.handle.net/11392/2487987.
Повний текст джерелаBackground. Leishmaniases (VL) represents a major health problem. The first part of the thesis evaluates by molecular techniques and cytokine analysis the prevalence of asymptomatic Leishmania infections in autoimmune rheumatic patients treated with biological drugs and living in Leishmania endemic foci in Italy. In the second part, the effect of the niacin analogue, 6-AN on Leishmania parasite growth and metabolism using the metabolomics technology was investigated. The pentose phosphate pathway (PPP), has been reported as a target of 6-AN, thus PPP might represent a good target. Methods. VL qualitative and real-time PCR were performed on DNA extracted from PBMCs from 50 autoimmune rheumatic patients treated with immunosuppressive biologic drugs for at least 5 years. Plasma cytokine concentrations were also measured in plasma from Leishmania DNA-positive and -negative rheumatic patients as well as from the healthy control group. In the 6-AN study, L. mexicana M379 and L. infantum PCM5 promastigotes were treated with 7.8 mM 6-AN and 2.17% DMSO for 24 hours. After vitality, infectivity of 6-AN-treated promastigotes to mouse macrophages, and 6-AN interactions with oxidizing compounds were also studied. Small metabolites were extracted and analysed by pHILIC-LC-MS in polarity switching mode and data were analysed with IDEOMv19 and MetaboAnalyst 3.0. Results.Eighteen out the 50 (36%) autoimmune rheumatic patients were positive for Leishmania DNA by conventional and/or quantitative PCR with a detection of high parasite burdens (1 to 136 parasite/ml in 4 patients, 1.000 to 40.000 in 11 patients and over 1.000.000 in 3 patients). Patients that were taking a steroid in association with the biological drug showed a higher positivity for circulating L. infantum kDNA than those given the biological drug only (p<0.05). Pro-inflammatory IL-1, IL-6, IL-12(p70), IL-7, IL-15, IFN-γ and TNF-α; anti-inflammatory IL-4, IL-13; and regulatory IL-10 cytokines were markedly elevated in all autoimmune rheumatic patients with additional increases in inflammatory mediators in autoimmune rheumatic patients positive for Leishmania DNA. In both L. mexicana and L. infantum, 6-AN caused significant depletion of phosphoribosylpyrophosphate (PRPP) and nicotinate (Na) and as a result purine and pyrimidine nucleotides were reduced and their nucleobases accumulated. Glutathione, ribose-5-phosphate, 6-phosphogluconate levels and downstream PPP intermediates were similar to controls. For L. infantum, it was possible to analyse NAD+ and NADPH, which were found decreased together with the PPP intermediate D-sedoheptulose 7-phosphate. Moreover, 6-AN treatment caused a marked elongation in parasite body. 6-AN in combination with the oxidizing compounds has additive effects against Leishmania and did not affect the infectivity of the treated promastigotes to mouse macrophages. Conclusions.VL molecular screening and cytokine analysis should be taken into account before treating autoimmune rheumatic patients with biologic drugs, especially in rural areas. In mammals 6-AN is converted to abnormal 6-ANAD/P by NAD+ glycohydrolase, however, in Leishmania its toxicity is only seen in millimolar range, in which 6-AN is responsible for the depletion of cellular phosphoribosyl pyrophosphate (PRPP) content probably in the Preiss-Handler NAD+ salvage pathway, resulting in depletion of nucleotides required for nucleic acid biosynthesis. The marked elongation in the 6-AN-treated parasite bodies confirms nucleotide starvation. Leishmania NAD+ glycohydrolase might decompose NAD+ but might not catalyze exchange reactions, as found in other microrganisms, however, combined 13C-glucose labeling and flux analysis might be useful to ascertain the fate and action mechanism of 6-AN in Leishmania. In addition, PRPP synthetase should also be a good target for new potential drugs against leishmaniasis pointing to the growth-inhibitory effect of PRPP depletion.
Boraschi, Cláudia Souza e. Silva [UNESP]. "Inquérito sobre o conhecimento da população da cidade de Três Lagoas – MS sobre leishmaniose visceral." Universidade Estadual Paulista (UNESP), 2007. http://hdl.handle.net/11449/94685.
Повний текст джерелаCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
A leishmaniose visceral (LV) é um importante problema de saúde pública e as medidas de prevenção preconizadas nem sempre são conhecidas pela população. Esta pesquisa avaliou, por meio da aplicação de um questionário, o conhecimento que a população de Três Lagoas, MS tem sobre esta zoonose. Dos 384 entrevistados, 100% afirmaram que já tinham conhecimento prévio da LV, 64,5% sabiam que é transmitida através do inseto vetor e 65,4% sabiam que a prevenção se dá evitando o criadouro deste. Observaram-se 93,5% de respostas para manutenção do quintal limpo como medida preventiva conhecida. Pelo menos um método de prevenção era utilizado no animal por 50,5% dos entrevistados e observou-se associação estatisticamente significante entre o grupo de proprietários cujos cães nunca apresentaram leishmaniose visceral canina e o grupo que fazia uso de alguma prevenção no animal (p=0,0006).
Visceral Leishmaniasis (VL) is an important public health problem and the measures to prevent it are not always known by the population. This research evaluated the knowledge that the population of Três Lagoas, MS, Brazil has about this zoonosis. One hundred percent of the interviewed (384) had previous knowledge of the disease, 64.5% knew that a vector transmits it and 65.4% knew that the prevention is achieved by preventing vector’s breeding sites. Maintenance of the backyard clean was informed by 93,5% as a known preventive measure. At least one preventive method was used in the animal by 51% of the interviewed ones and statically significant association between the group of owners whose dogs had never presented canine visceral leishmaniasis and owners that used some preventive method in the animal (p=0.0006) was observed.
Sánchez, Fabio. "Genetic factors influencing susceptibility to intracellular infections /." Stockholm, 2002. http://diss.kib.ki.se/2002/91-7349-225-6.
Повний текст джерелаCollar, Catharine Jane. "Rational Drug Design for Neglected Diseases: Implementation of Computational Methods to Construct Predictive Devices and Examine Mechanisms." Digital Archive @ GSU, 2010. http://digitalarchive.gsu.edu/chemistry_diss/48.
Повний текст джерелаBhattacharyya, T. "Parasite diversity and innovative serology : development of Trypanosoma cruzi lineage-specific diagnosis of Chagas disease and of prognostic assays for visceral leishmaniasis." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2015. http://researchonline.lshtm.ac.uk/2173663/.
Повний текст джерелаFurini, Júnior. "Estratégias terapêuticas usando o ácido ursólico sobre infecções determinadas por tripanosomatideos." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/60/60135/tde-12122016-154937/.
Повний текст джерелаChagas disease and Leishmaniasis are diseases caused by protozoa of the family Trypanosomatidae (Trypanosoma cruzi and Leishmania sp., Respectively) and both are in the group of diseases considered neglected tropical (NTDs). All together, they affect about 30 million people in 98 countries worldwide. Although so very epidemiologically important, these diseases still lack a safe and robust chemotherapeutic treatment seeing that the available drugs present besides low therapeutic efficacy, low compliance rates, since they are extremely toxic and cause serious side effects ending up, therefore, being resistance generators. In recent decades, there have been intense efforts of research groups to develop alternatives for treating these diseases, especially exploring natural products and by applying pharmaceutical technology, generating more clinically viable formulations due to providing favorable physicochemical properties to the cell absorption and permeability, thus resulting in increased bioavailability and enhancement of biological effect. In our present study, we aimed to propose new treatment strategies for these diseases by using as a candidate, the ursolic acid (UA), a naturally occurring triterpenoid. Isolated UA and associated with established drugs have been tested, as well as a solid dispersion containing 10% of the active ingredient (SDUA). In the in vitro tests against several extracellular and intracellular evolving forms of Trypanosoma cruzi and Leishmania braziliensis, we have obtained very good results, such as 99.8 of lysis at 128 ?M on trypomastigotes, with IC50 of 14.1 ?M for the UA. In the in vivo experiments about experimental Chagas disease, a decrease of parasitaemi of 60.2% and 61.6% has been observed in animals treated with doses of 20 mg / kg of UA and SDUA respectively. Although not having caused a decrease in the parasite load in the tissues analyzed (heart and liver) compared to the negative control, the PFS of animals treated with UA and SDUA was similar to that of the animals treated with the same dose of benznidazole. About the experimental skin mucus leishmaniasis, we have observed a decrease of the average diameter of lesions in animals treated with 20 mg / kg of our evaluated compounds. These results demonstrate that the ursolic acid is a potent candidate for chemotherapy for the treatment of trypanosomiasis. Furthermore, the association of existing drugs, and the use of pharmaceutical technology can be good strategies to treat these diseases
Boraschi, Cláudia Souza e. Silva. "Inquérito sobre o conhecimento da população da cidade de Três Lagoas - MS sobre leishmaniose visceral /." Araçatuba : [s.n.], 2007. http://hdl.handle.net/11449/94685.
Повний текст джерелаBanca: Mary Marcondes
Banca: Sonia Regina Pinheiro
Resumo: A leishmaniose visceral (LV) é um importante problema de saúde pública e as medidas de prevenção preconizadas nem sempre são conhecidas pela população. Esta pesquisa avaliou, por meio da aplicação de um questionário, o conhecimento que a população de Três Lagoas, MS tem sobre esta zoonose. Dos 384 entrevistados, 100% afirmaram que já tinham conhecimento prévio da LV, 64,5% sabiam que é transmitida através do inseto vetor e 65,4% sabiam que a prevenção se dá evitando o criadouro deste. Observaram-se 93,5% de respostas para manutenção do quintal limpo como medida preventiva conhecida. Pelo menos um método de prevenção era utilizado no animal por 50,5% dos entrevistados e observou-se associação estatisticamente significante entre o grupo de proprietários cujos cães nunca apresentaram leishmaniose visceral canina e o grupo que fazia uso de alguma prevenção no animal (p=0,0006).
Abstract: Visceral Leishmaniasis (VL) is an important public health problem and the measures to prevent it are not always known by the population. This research evaluated the knowledge that the population of Três Lagoas, MS, Brazil has about this zoonosis. One hundred percent of the interviewed (384) had previous knowledge of the disease, 64.5% knew that a vector transmits it and 65.4% knew that the prevention is achieved by preventing vector's breeding sites. Maintenance of the backyard clean was informed by 93,5% as a known preventive measure. At least one preventive method was used in the animal by 51% of the interviewed ones and statically significant association between the group of owners whose dogs had never presented canine visceral leishmaniasis and owners that used some preventive method in the animal (p=0.0006) was observed.
Mestre
Zuque, Maria Angelina da Silva. "Participação de gambás e cães domiciliados como reservatórios de Leishmania infantum e Trypanosoma cruzi georreferenciados nos municípios da Regional de Saúde de Três Lagoas - MS." Botucatu, 2016. http://hdl.handle.net/11449/136267.
Повний текст джерелаResumo: A Leishmaniose Visceral e a Doença de Chagas são importantes zoonoses negligenciadas do ponto de vista de saúde pública. Animais domésticos, como o cão, e animais silvestres, como os gambás, fazem parte do ciclo destas zoonoses como fontes de infecção para os vetores. O estudo foi realizado em cinco municípios da Regional de Saúde de Três Lagoas, Mato Grosso do Sul, em 2013 e 2014, com objetivo de identificar a ocorrência da infecção natural por Leishmania spp e Trypanosoma cruzi em gambás (Didelphis albiventris) e cães domiciliados, descrever aspectos epidemiológicos dessas doenças na população canina e humana, seus vetores, e a distribuição espacial da Leishmaniose Visceral Canina usando técnicas do georrefenciamento. Amostras de sangue dos cães foram submetidas a análises sorológicas e moleculares, e a dos gambás somente as análises moleculares. Em relação à pesquisa de anticorpos contra a Leishmania spp., as provas sorológicas de 683 amostras dos cães, revelaram reagentes 320 amostras ao Dual Path Platform, 300 amostras ao Enzyme Linked Immunosorbent Assay e 116 a Reação de Imunofluorescência Indireta. Para Trypanosoma cruzi, pela Reação de Imunofluorescência Indireta, quatro amostras do município de Três Lagoas foram reagentes. Das 683 amostras de sangue total, dos cães submetidas à Reação em Cadeia pela Polimerase, todas foram negativas para Trypanosoma cruzi e obteve-se êxito na amplificação de Leishmania spp em 17 amostras. As 39 amostras de sangue total dos gambás fo... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: Visceral Leishmaniasis (VL ) and Chagas disease (CD ) are important neglected zoonoses in accordance with public health. Domestic animals such as dogs and wildlife such as possums , are part of these zoonoses cycles as reservoirs and sources of infection for vectors. The study was conducted in five Regional Health of the municipalities of Três Lagoas , Mato Grosso do Sul in 2013 and 2014 , in order to verify the occurrence of natural infection with Leishmania infantum and Trypanosoma cruzi in opossums (Didelphis albiventris) and the pet dogs, and describe the characteristics of diseases in human and canine population , vectors , and the spatial distribution of canine Visceral Leishmaniasis using techniques georrefenciamento. In dog´s blood there were performed serological analysis and molecular tests ande the samples of the opossums were performed molecular tests. Regarding the research for Leishmania antibodies the techniques serological to 683 dog samples, showed reagent 320 samples to Dual Path Platform, 300 samples to Enzyme Linked Immunosorbent Assay and 116 to Immunofluorescence Antibody Test. For Trypanosoma cruzi, the test Immunofluorescence Antibody Test (IFAT) four samples of Três Lagoas municipality were reactive. Of the samples from dogs 683 submitted to the Polymerase Chain Reaction were all negative by Trypanosoma cruzi gave successful amplification Leishmania spp in 17 of them. The 39 samples of the opossums were all negative by PCR to Leishmania spp. and Trypa... (Complete abstract click electronic access below)
Doutor
Barbosa, Sofia Diniz de Nazaré. "A leishmaniose canina e os condicionalismos determinados pelas respectivas alterações renais." Bachelor's thesis, Universidade Técnica de Lisboa. Faculdade de Medicina Veterinária, 2011. http://hdl.handle.net/10400.5/3548.
Повний текст джерелаA Leishmaniose é uma doença zoonótica causada pelo protozoário da espécie Leishmania infantum, que existe predominantemente na Bacia do Mediterrâneo. O ciclo de vida deste parasita requer a existência de um vector, um insecto do género Phlebotomus, que é responsável pela transmissão das formas infectantes, os promastigotas metacíclicos, aos hospedeiros vertebrados, nomeadamente os canídeos. Em Portugal, apenas as espécies P. ariasi e P. perniciosus são vectores comprovados de L. infantum. As características clínicas da Leishmaniose canina variam amplamente como consequência dos numerosos mecanismos patogénicos do protozoário, da diversidade de respostas imunológicas desenvolvidas nos hospedeiros e dos diferentes órgãos afectados. A doença renal pode ser a única manifestação clínica nos animais infectados, podendo progredir de proteinúria assintomática até síndrome nefrótico ou Insuficiência Renal Crónica, que é responsável pela degradação do estado geral e a principal causa de morte nos cães com Leishmaniose. A aplicação do tratamento adequado requer, previamente, um diagnóstico precoce da doença e a avaliação do estado sanitário e imunitário do animal, através do exame clínico e de exames complementares, que devem ser repetidos a cada 6 meses. A presença de Insuficiência Renal Crónica impõe algumas limitações no tratamento da Leishmaniose canina, sendo fundamental seleccionar cautelosamente os fármacos e respectivas doses a administrar a cada paciente. Neste estudo retrospectivo foram observados 19 canídeos com Leishmaniose, sendo a sua sintomatologia muito variável, da qual se destaca a linfadenopatia, o emagrecimento e as lesões dermatológicas. As alterações laboratoriais mais frequentes foram a anemia não-regenerativa, a trombocitopénia, a hiperproteinémia com hiperglobulinémia e a proteinúria. O diagnóstico etiológico foi realizado com base nas técnicas de imunocromatografia rápida e de imunofluorescência indirecta. Foi também diagnosticada Insuficiência Renal Crónica em 4 canídeos da amostra. Diferentes fármacos foram utilizados no tratamento etiológico e sintomático, porém foi mais frequente a administração de alopurinol em monoterapia ou em associação com o antimoniato de glucamina.
ABSTRACT - CANINE LEISHMANIASIS AND CONSTRAINTS DETERMINED BY THEIR RENAL CHANGES - Leishmaniasis is a zoonotic disease caused by the protozoan Leishmania infantum, which is the most common species of Leishmania in the Mediterranean basin. The life cycle of this parasite requires the existence of a vector, the insect of the genus Phlebotomus, which is responsible for the transmission of infectious form, the metacyclic promastigotes, to the vertebrate host, namely the dog. In Portugal, only the species P. ariasi and P. perniciosus are proven vectors of L. infantum. The clinical features of canine Leishmaniasis are highly variable as a consequence of the numerous pathogenic mechanisms, the diversity of immune responses of individual hosts and the different organs affected. Renal disease may be the only clinical manifestation in infected dogs and may progress from asymptomatic proteinuria to nephrotic syndrome or to Chronic Kidney Disease, which is responsible for the deterioration of general condition and leading cause of death in dogs with Leishmaniasis. The application of suitable treatment requires, previously, an early diagnosis and assessment of dog’s health and immunity status, by clinical examination and several routine diagnostic tests, which must be repeated every six months. The presence of Chronic Kidney Disease imposes some limitations in the treatment of canine Leishmaniasis and is necessary to select carefully the drugs and doses to be administered in each patient. In this retrospective study, 19 dogs with Leishmaniasis were observed and many clinical signs were found, mainly lymphadenopathy, weight loss and dermatologic lesions. The most frequent laboratory abnormalities were non-regenerative anemia, thrombocytopenia, hyperproteinemia with hyperglobulinemia and proteinuria. The definitive diagnosis was made by a rapid immunomigration test and indirect fluorescent antibody technique. Chronic Kidney Disease was also diagnosed in 4 dogs of sample. Different drugs were used in the etiological and symptomatic treatment, but the administration of alopurinol alone or in combination with glucamine antimoniate were the most frequent.
Книги з теми "Leishmaniasis-Disease"
J, Farrell, ed. Leishmania. Boston, Mass: Kluwer Academic Pub., 2002.
Знайти повний текст джерелаDrugs for Neglected Diseases Initiative. An innovative solution. [Geneva]: DNDi, 2004.
Знайти повний текст джерелаInternational, Symposium on Phlebotomine Sandflies (1st 1991 Rome Italy). First International Symposium on Phlebotomine Sandflies: Rome, Italy, 4-6 September 1991 : abstract book. Roma: Istituto superiore di sanità, 1991.
Знайти повний текст джерелаde Azevedo Calderonon, Leonardo, ed. Leishmaniasis - General Aspects of a Stigmatized Disease. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.95200.
Повний текст джерелаCalderon, Leonardo de Azevedo. Leishmaniasis: General Aspects of a Stigmatized Disease. IntechOpen, 2022.
Знайти повний текст джерелаWolstenholme, G. E. W., Katherine Elliott, and Maeve O'Connor. Trypanosomiasis and Leishmaniasis: With Special Reference to Chagas' Disease. Wiley & Sons, Incorporated, John, 2009.
Знайти повний текст джерелаStaff, CIBA Foundation Symposium. Trypanosomiasis and Leishmaniasis: With Special Reference to Chagas' Disease. Wiley & Sons, Limited, John, 2008.
Знайти повний текст джерелаWorld Health Organization (WHO) and Human African Trypanosomiasis and Leishmaniasis TDR Disease Reference Group on Chagas Disease. Research Priorities for Chagas Disease, Human African Trypanosomiasis and Leishmaniasis. WHO Regional Office for the Western Pacific, 2012.
Знайти повний текст джерелаFarrell, Jay P. Leishmania. Springer London, Limited, 2012.
Знайти повний текст джерелаRivera, Gildardo, Navin B. Patel, and Debasish Bandyopadhyay, eds. Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88971-792-7.
Повний текст джерелаЧастини книг з теми "Leishmaniasis-Disease"
Coelho, Eduardo A. F., and Myron Christodoulides. "Vaccines for Canine Leishmaniasis." In Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges, 281–306. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-24355-4_13.
Повний текст джерелаFarrell, Jay P., Thomas J. Nolan, William L. Croop, and Carl E. Kirkpatrick. "A Possible Role for Prostaglandins in Regulation of Disease in Murine Cutaneous Leishmaniasis." In Leishmaniasis, 345–52. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1575-9_42.
Повний текст джерелаCampino, Lenea Maria. "Canine Reservoirs and Leishmaniasis: Epidemiology and Disease." In World Class Parasites, 45–57. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0955-4_4.
Повний текст джерелаRead, Amber, Ivy Hurwitz, and Ravi Durvasula. "Leishmaniasis: An Update on a Neglected Tropical Disease." In Dynamic Models of Infectious Diseases, 95–138. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-3961-5_4.
Повний текст джерелаTrager, William. "Immunology of Leishmaniasis and American Trypanosomiasis (Chagas’ Disease)." In Living Together, 309–19. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4615-9465-9_20.
Повний текст джерелаRecacoechea, M., G. Villarroel, S. Balderrama, R. Urjel, S. De Doncker, D. Jacquet, and D. Le Ray. "Leishmaniasis in the Lowlands of Bolivia (Leishbol): Part III. Status of the Disease in an Area of Spontaneous Agricultural Colonization." In Leishmaniasis, 109–15. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1575-9_14.
Повний текст джерелаFarrell, Jay P. "The Immunology of Cutaneous Leishmaniasis: Experimental Infections and Human Disease." In World Class Parasites, 151–68. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0955-4_11.
Повний текст джерелаOsada, Yasutaka, Satoko Omachi, Chizu Sanjoba, and Yoshitsugu Matsumoto. "Animal Models of Visceral Leishmaniasis and Applicability to Disease Control." In Kala Azar in South Asia, 287–96. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-47101-3_23.
Повний текст джерелаAvila, José Luis. "α-Galactosyl-Bearing Epitopes as Potent Immunogens in Chagas’ Disease and Leishmaniasis". У α-Gal and Anti-Gal, 173–213. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4771-6_8.
Повний текст джерелаde Carvalho Clímaco, Marianna, Lucas Kraemer, and Ricardo Toshio Fujiwara. "Vaccine Development for Human Leishmaniasis." In Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges, 307–26. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-24355-4_14.
Повний текст джерелаТези доповідей конференцій з теми "Leishmaniasis-Disease"
Durvasula, Ravi. "Paratransgenic strategies to control transmission of Chagas disease and leishmaniasis." In 2016 International Congress of Entomology. Entomological Society of America, 2016. http://dx.doi.org/10.1603/ice.2016.92857.
Повний текст джерелаAmoli, Golnush Masghati. "GIS-based risk map analysis of Leishmaniasis disease in Isfahan, Iran." In 2011 IEEE Symposium on Business, Engineering and Industrial Applications (ISBEIA). IEEE, 2011. http://dx.doi.org/10.1109/isbeia.2011.6088820.
Повний текст джерелаMontolio-Chiva, L., Elia Valls-Pascual, D. Ybáñez-García, À. Martínez-Ferrer, Marta Aguilar-Zamora, Ana V. Orenes Vera, I. Vázquez-Gómez, et al. "FRI0682 LEISHMANIASIS IN PATIENTSWITH CHRONIC INFLAMMATORY DISEASE TREATED WITH IMMUNOMODULATORS. MULTICENTER ANALYSIS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.5992.
Повний текст джерелаGuagchinga Moreno, Genesis Yulisa, Andrea Carolina Serrano Larrea, Frank Alexis, and Javier Santamaría. "Cellulose-based beads as a possible method for drug release in the treatment of Leishmaniasis disease." In VIII Congreso Internacional de Investigación REDU. Medwave, 2022. http://dx.doi.org/10.5867/medwave.2022.s1.ci26.
Повний текст джерелаSILVA, SERGIO E. LEMOS DA, BRUNA SCARPELLI PEDROSA VIEIRA, BRUNO RODRIGO DE MEDEIROS, EMILLENE MARIA SILVA OLIVEIRA, JULIANA DA CONCEIçãO SILVA FIGUEIREDO, and MARIA DAGUIJARA SANTOS SILVA. "HEALTH INDICATORS OF CANINE VISCERAL LEISHMANIASIS AS TOOLS FOR CONTROL AND PREVENTION IN BRAZIL." In II South Florida Congress of Development. brazco, 2022. http://dx.doi.org/10.47172/iisfcdv2022.0022.
Повний текст джерелаFERREIRA, Lucas Leal, Amanda Alfeld BELEGOTE, Laís Freire SILVA, Steffany Souza CABRAL, and Priscilla Nunes DOS SANTOS. "SEROPREVALENCE AND CLINICAL MANIFESTATIONS OF DOMICILED DOGS (CANIS LUPUS FAMILIARIS) CLOSE TO A HUMAN CASE OF VISCERAL LEISHMANIASIS." In SOUTHERN BRAZILIAN JOURNAL OF CHEMISTRY 2021 INTERNATIONAL VIRTUAL CONFERENCE. DR. D. SCIENTIFIC CONSULTING, 2022. http://dx.doi.org/10.48141/sbjchem.21scon.30_abstract_ferreira.pdf.
Повний текст джерелаSlobodyanik, R. V., S. S. Zykova, and O. V. Shcherbakov. "CASES OF LEISHMANIASIS AMONG STRAY DOGS IN SETTLEMENTS OF THE SYUNIK AND ARARAT REGIONS OF ARMENIA." In THEORY AND PRACTICE OF PARASITIC DISEASE CONTROL. All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV”, 2023. http://dx.doi.org/10.31016/978-5-6048555-6-0.2023.24.436-440.
Повний текст джерелаSinha, Sukrat. "IDDF2018-ABS-0256 Clinical and hepatological profile of a patient suffering from visceral leishmaniasis." In International Digestive Disease Forum (IDDF) 2018, Hong Kong, 9–10 June 2018. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2018. http://dx.doi.org/10.1136/gutjnl-2018-iddfabstracts.238.
Повний текст джерелаSinha, Sukrat. "IDDF2019-ABS-0177 Modulation of antimony mediated therapy for an optimal insulin secretion during visceral leishmaniasis." In International Digestive Disease Forum (IDDF) 2019, Hong Kong, 8–9 June 2019. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2019. http://dx.doi.org/10.1136/gutjnl-2019-iddfabstracts.183.
Повний текст джерелаЗвіти організацій з теми "Leishmaniasis-Disease"
Baldeviano, Geral C. Development of Novel Therapeutics for Neglected Tropical Disease Leishmaniasis. Fort Belvoir, VA: Defense Technical Information Center, October 2015. http://dx.doi.org/10.21236/ad1008742.
Повний текст джерелаSatoskar, Abhay. Development of Novel Therapeutics for Neglected Tropical Disease Leishmaniasis. Fort Belvoir, VA: Defense Technical Information Center, October 2015. http://dx.doi.org/10.21236/ada637013.
Повний текст джерелаSaenz, Rolando E. Research on Defense Against the Effects of Parasitic Disease. Pilot Study on the Efficacy of Pentostam in the Treatment of Mucocutaneous Leishmaniasis (MCL). Fort Belvoir, VA: Defense Technical Information Center, November 1990. http://dx.doi.org/10.21236/ada230244.
Повний текст джерела